- Home
- MIRA vs XAIR Comparison
MIRA vs XAIR Comparison
Compare MIRA & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIRA
- XAIR
- Stock Information
- Founded
- MIRA 2020
- XAIR 2011
- Country
- MIRA United States
- XAIR United States
- Employees
- MIRA N/A
- XAIR N/A
- Industry
- MIRA Biotechnology: Pharmaceutical Preparations
- XAIR Medical/Dental Instruments
- Sector
- MIRA Health Care
- XAIR Health Care
- Exchange
- MIRA Nasdaq
- XAIR Nasdaq
- Market Cap
- MIRA 19.5M
- XAIR 17.0M
- IPO Year
- MIRA 2023
- XAIR N/A
- Fundamental
- Price
- MIRA $1.25
- XAIR $0.16
- Analyst Decision
- MIRA Strong Buy
- XAIR Buy
- Analyst Count
- MIRA 2
- XAIR 3
- Target Price
- MIRA $14.00
- XAIR $1.50
- AVG Volume (30 Days)
- MIRA 168.5K
- XAIR 5.5M
- Earning Date
- MIRA 08-12-2025
- XAIR 06-17-2025
- Dividend Yield
- MIRA N/A
- XAIR N/A
- EPS Growth
- MIRA N/A
- XAIR N/A
- EPS
- MIRA N/A
- XAIR N/A
- Revenue
- MIRA N/A
- XAIR $3,705,000.00
- Revenue This Year
- MIRA N/A
- XAIR $286.75
- Revenue Next Year
- MIRA N/A
- XAIR $144.39
- P/E Ratio
- MIRA N/A
- XAIR N/A
- Revenue Growth
- MIRA N/A
- XAIR 219.67
- 52 Week Low
- MIRA $0.51
- XAIR $0.15
- 52 Week High
- MIRA $5.01
- XAIR $0.68
- Technical
- Relative Strength Index (RSI)
- MIRA 46.62
- XAIR 43.11
- Support Level
- MIRA $1.15
- XAIR $0.15
- Resistance Level
- MIRA $1.30
- XAIR $0.29
- Average True Range (ATR)
- MIRA 0.08
- XAIR 0.03
- MACD
- MIRA -0.01
- XAIR -0.00
- Stochastic Oscillator
- MIRA 21.43
- XAIR 7.41
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.